SIMmersion, in collaboration with the Institute for Family Health (IFH) and the Educational Development Center (EDC) propose to develop a web-based training product, Suicide Prevention Role-plays for Interactive Training (SPiRIT), a series of 4 modules to train providers to more effectively manage patients who screen positive for risk of suicide in this Phase I/Phase II fast-track application. If funded, the team will develop the Risk Assessment module in Phase I and utilize a within group pre-post design to evaluate its feasibility. Twenty practicing clinicians will be recruited to utilize the module and complete a pre-post knowledge test. In Phase II, the team will develop Safety Planning, Access to Lethal Means, and Willingness to Accept a Referral modules. The efficacy of the product to positively influence patient outcomes will be tested with a Historically Controlled Trial (HCT) enlisting 65 practicing clinicians across five IFH sites. All providers will be trained and patient outcomes will be tracked for 6 months post training. This data set will be compared to 6 months of historical data for the same provider group. Primary outcomes of this study will measure the participants' ability in obtain improved patient outcomes related to: 1) rate of same-day C-SSRS Screening; 2) rate of suicide being added to the problem list; 3) rate of same-day safety planning; 4) rate of same day C-SSRS Lifeline/Recent Completion; 5) rate of same-day Risk Assessment; 6) rate of acceptance and attendance to within-Institute referrals for post intervention patients who are offered the referral at the first visit; 7) and lower rates of documented suicide attempts. Ultimately, the development and successful testing of this product would provide the US health care system a novel technology to scale up a clinician's confidence and skill to better manage patients who identify as at-risk for suicide. Additionally, if effective, this product will have a direct impact on patient outcomes, a vital component to any training product that attempts to train health care professionals. The utility and scalability of the proposed product will move health care systems toward the goal of zero deaths from suicide consistent with the Zero suicide approach.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
91
A series of 4 modules to train providers to more effectively manage patients who screen positive for risk of suicide. The modules are: Risk Assessment, Safety Planning, Access to Lethal Means, and Willingness to accept referral.
C-SSRS Screening
Higher rates of same-day C-SSRS Screening
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
Suicide addition to Problem List
Higher rates of suicide being added to the problem list
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
Same-day Safety Planning, if a positive screen
Higher rates of same-day Safety Planning, if a positive screen
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
C-SSRS Lifeline/Recent Completion
Higher rates of same-day C-SSRS Lifeline/Recent Completion, if a positive screen;
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
Risk Assessment
Higher rates of same-day Risk Assessment, if a positive screen
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
Within-Institute referrals
Higher rates of acceptance and attendance to within-Institute referrals for post intervention patients who are offered the referral at the first visit
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
Documented suicide attempts
Have lower rates of documented suicide attempts
Time frame: Assessment will occur after a 6 month period of tracking patient records for each provider
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.